Detalhe da pesquisa
1.
The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics.
BMC Endocr Disord
; 21(1): 232, 2021 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801015
2.
Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey.
Clin Endocrinol (Oxf)
; 92(2): 159-168, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721256
3.
TRENDS IN GROWTH HORMONE STIMULATION TESTING AND GROWTH HORMONE DOSING IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: RESULTS FROM THE ANSWER PROGRAM.
Endocr Pract
; 22(4): 396-405, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26574788
4.
Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
J Pediatr
; 167(6): 1389-96, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394822
5.
Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations.
Clin Endocrinol (Oxf)
; 81(1): 71-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24428305
6.
Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels.
Clin Endocrinol (Oxf)
; 78(3): 405-14, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22924571
7.
Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers.
J Pediatr Nurs
; 28(1): 55-63, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22300524
8.
Comparison of human growth hormone products' cost in pediatric and adult patients. A budgetary impact model.
Manag Care
; 16(9): 45-51, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17969748
9.
Efficacy and safety of hypoglycemic drugs in children with type 2 diabetes mellitus.
Pharmacotherapy
; 25(6): 803-9, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15927898
10.
Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Growth Horm IGF Res
; 25(6): 286-93, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26363846
11.
Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Program.
Int J Pediatr Endocrinol
; 2015(1): 1, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25904938
12.
Noonan syndrome and Turner syndrome patients respond similarly to 4 years' growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program.
Int J Pediatr Endocrinol
; 2015(1): 17, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26351466
13.
Prepubertal children with growth hormone deficiency treated for four years with growth hormone experience dose-dependent increase in height, but not in the rate of puberty initiation.
Horm Res Paediatr
; 80(1): 28-37, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816571
14.
The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®).
Clin Epidemiol
; 5: 119-27, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23658497
15.
Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry.
Int J Pediatr Endocrinol
; 2012(1): 15, 2012 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22682146
16.
Klinefelter syndrome presenting with precocious puberty due to a human chorionic gonadotropin (hCG)-producing mediastinal germinoma.
J Pediatr Endocrinol Metab
; 19(11): 1371, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17220068
17.
Impact of age and duration of growth hormone therapy in children with Turner syndrome.
Horm Res Paediatr
; 76(6): 392-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156541
18.
Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®.
Int J Pediatr Endocrinol
; 2011: 6, 2011 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21899782
19.
Factors influencing the one- and two-year growth response in children treated with growth hormone: analysis from an observational study.
Int J Pediatr Endocrinol
; 2010: 494656, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20981140
20.
Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
J Clin Endocrinol Metab
; 95(5): 2089-98, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20207829